Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts

Cardiovascular Research

Volumn 103, Issue 1, 2014, Pages 28-36

  Laschkolnig, Anja ^a   Kollerits, Barbara ^a   Lamina, Claudia ^a   Meisinger, Christa ^b   Rantner, Barbara ^a   Stadler, Marietta ^c   Peters, Annette ^b   Koenig, Wolfgang ^d   Stöckl, Andrea ^a   Dähnhardt, Doreen ^a   Böger, Carsten A ^e   Krämer, Bernhard K ^f   Fraedrich, Gustav ^a   Strauch, Konstantin ^b,g   Kronenberg, Florian ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Hietzing Hospital   (Austria)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g UNIVERSITY OF MUNICH   (Germany)

Author keywords

Ankle brachial index; Apolipoprotein(a) phenotypes; Causality; Lp(a) concentrations; Mendelian randomization; Peripheral arterial disease

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A;

ADULT; ALLELE; ANKLE BRACHIAL INDEX; ARTICLE; ASYMPTOMATIC DISEASE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; DIABETES MELLITUS; DISEASE ASSOCIATION; INSTRUMENTAL VARIABLE ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; AGED; BLOOD; CHEMISTRY; GENETIC PREDISPOSITION; GENETICS; MOLECULAR WEIGHT; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; ANKLE BRACHIAL INDEX; APOPROTEIN(A); COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERMITTENT CLAUDICATION; LINEAR MODELS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MOLECULAR WEIGHT; PERIPHERAL ARTERIAL DISEASE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84903971393     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu107     Document Type: Article

References (39)

1. Kronenberg F, Utermann G. Lipoprotein(a)-resurrected by genetics. J Intern Med 2013; 273:6-30.
2. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987;80:458-465.
3. Sandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, Hoppichler F, Boerwinkle E, Utermann G. Apo(a) isoforms predict risk for coronary heart disease: a study in six populations. Arterioscler Thromb 1992;12:1214-1226.
4. Erqou S, Kaptoge S, Perry PL, Di AE, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009;302:412-423.
5. Erqou S, Thompson A, Di AE, Saleheen D, Kaptoge S, Marcovina S, Danesh J. Apolipoprotein( a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants. J Am Coll Cardiol 2010;55:2160-2167.
6. Kronenberg F. Lipoprotein(a): there's life in the old dog yet. Circulation 2014;129: 619-621.
7. ShammasNW. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag 2007;3:229-234.
8. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110:738-743.
9. Ostchega Y, Paulose-Ram R, Dillon CF,GuQ, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc 2007;55:583-589.
10. Lamina C, Meisinger C, Heid IM, Löwel H, Rantner B, KoenigW, Kronenberg F, for the KORA Study Group. Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13-years of follow-up. Eur Heart J 2006;27:2580-2587.
11. Kollerits B, Heinrich J, Pichler M, Rantner B, Klein-Weigel P, Wö lke G, Brasche S, Strube G, Kronenberg F. Intermittent claudication in the Erfurt Male Cohort (ERFORT) Study: its determinants and the impact on mortality.Apopulation-based prospective cohort study with 30 years of follow-up. Atherosclerosis 2008;198:214-222.
12. Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Darius H, Burghaus I, Trampisch HJ. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009;120:2053-2061.
13. Kollerits B, Sturm G, Lamina C, Hammerer-Lercher A, Rantner B, Stadler M, Ziera T, Struck J, Klein-Weigel P, Fraedrich G, Kronenberg F. Comparison and evaluation of cardiac biomarkers in patients with intermittent claudication: results from the CAVASIC Study. Clin Chem 2013;59:692-702.
14. Rantner B, Kollerits B, Anderwald-Stadler M, Klein-Weigel P, Gruber I, Gehringer A, Haak M, Schnapka-Köpf M, Fraedrich G, Kronenberg F. Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC Study. Clin Chem 2008;54:851-857.
15. Heid IM, Henneman P, Hicks A, Coassin S, Winkler T, Aulchenko YS, Fuchsberger C, Song K, Hivert MF, Waterworth DM, Timpson NJ, Richards JB, Perry JRB, Tanaka T, Amin N, Kollerits B, Pichler I, Oostra BA, Thorand B, Frants RR, Illig T, Dupuis J, Glaser B, Spector T, Guralnik J, Egan JM, Florez JC, Evans DM, Soranzo N, Bandinelli S, Carlson OD, Frayling TM, Burling K, Davey SG, Mooser V, Ferrucci L, Meigs JB, Vollenweider P, Van DijkKW, Pramstaller P, Kronenberg F, Van Duijn CM. Clear detection ofADIPOQlocus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010;208: 412-420.
16. Stö ckl D,Dö ring A, Thorand B, Heier M, Peters A, Lamina C, Kronenberg F, Meisinger C. Reproductive factors and its association with peripheral arterial disease in women aged 52-81 years: the KORA F4 study. Atherosclerosis 2013;228:224-229.
17. Kronenberg F, Lobentanz E-M, Kö nig P, Utermann G, Dieplinger H. Effect of sample storage on the measurement of lipoprotein(a), apolipoproteins B and A-IV, total and high-density lipoprotein cholesterol and triglycerides. J Lipid Res 1994;35:1318-1328.
18. Kronenberg F, Kuen E, Ritz E, Junker R, Kö nig P, Kraatz G, Lhotta K, Mann JFE, Müller GA, Neyer U, Riegel W, Riegler P, Schwenger V, Von Eckardstein A. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 2000;11:105-115.
19. Kamstrup PR, Nordestgaard BG. Lipoprotein(a) levels, isoform size, and risk of type 2 diabetes: a Mendelian Randomisation study. Lancet Diab Endocrinol 2013;1:220-227.
20. Eilers PH, Marx BD. Flexible smoothing with B-splines and penalties. Stat Sci 1996;11: 89-121.
21. Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokgozoglu L, Tybjaerg-Hansen A. Lipoprotein( a) as a cardiovascular risk factor: current status. Eur Heart J 2010;31:2844-2853.
22. Pedro-Botet J, Sentí M, Auguet T, Nogués X, Rubies-Prat J, Aubo C, Vidal-Barraquer F. Apolipoprotein(a) genetic polymorphism and serum lipoprotein(a) concentration in patients with peripheral vascular disease. Atherosclerosis 1993;104:87-94.
23. Mö lgaard J, Klausen IC, Lassvik C, Færgeman O, Gerdes LU, Olsson AG. Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudication. Arterioscler Thromb 1992;12:895-901.
24. Dieplinger B, Lingenhel A, Baumgartner N, Poelz W, Dieplinger H, Haltmayer M, Kronenberg F, Mueller T. Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease. Clin Chem 2007;53:1298-1305.
25. Ye Z, Ali Z, Klee GG, MosleyTH Jr, Kullo IJ. Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease. AmJ Hypertens 2013;26:495-502.
26. Gurdasani D, Sjouke B, Tsimikas S, Hovingh GK, Luben RN,WainwrightNW, Pomilla C, Wareham NJ, Khaw KT, Boekholdt SM, Sandhu MS. Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 2012;32:3058-3065.
27. Volpato S, Vigna GB, McDermott MM, Cavalieri M, Maraldi C, Lauretani F, Bandinelli S, Zuliani G, Guralnik JM, Fellin R, Ferrucci L. Lipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study). Am J Cardiol 2010;105:1825-1830.
28. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study. Eur Heart J 2007;28:354-362.
29. PradhanAD, Shrivastava S,CookNR, Rifai N, CreagerMA, Ridker PM. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation 2008;117:823-831.
30. Aboyans V, Criqui MH, Denenberg JO, Knoke JD, Ridker PM, Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 2006;113: 2623-2629.
31. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001;285: 2481-2485.
32. Bertoia ML, Pai JK, Lee JH, Taleb A, Joosten MM, Mittleman MA, Yang X, Witztum JL, Rimm EB, Tsimikas S, Mukamal KJ. Oxidation-specific biomarkers and risk of peripheral artery disease. J Am Coll Cardiol 2013;61:2169-2179.
33. McDermott MM, Guralnik JM, Tian L, Liu K, Ferrucci L, Liao Y, Sharma L, Criqui MH. Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol 2009;53:1056-1062.
34. Kraft HG, Lingenhel A, Kö chl S, Hoppichler F, Kronenberg F, Abe A, Mühlberger V, Schö nitzer D, Utermann G. Apolipoprotein(a) Kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol 1996;16:713-719.
35. Kronenberg F. Genetic determination of lipoprotein(a) and its association with cardiovascular disease. Convenient does not always mean better. J Intern Med 2014, in press.
36. Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Exp Gerontol 2009;44:136-160.
37. Catalano M, Cortelazzo A, Yilmaz Y, Perilli E, Carzaniga G, Emanuele E. The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease. Clin Chim Acta 2008;387:109-112.
38. Hopewell JC, Clarke R, Parish S, Armitage J, Lathrop M, Hager J, Collins R. Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study. Circ Cardiovasc Genet 2011;4:68-73.
39. Helgadottir A, Gretarsdottir S, Thorleifsson G,Holm H, Patel RS, GudnasonT, JonesGT, Van Rij AM, Eapen DJ, Baas AF, Tregouet DA, Morange PE, Emmerich J, Lindblad B, Gottsater A, Kiemeny LA, Lindholt JS, Sakalihasan N, Ferrell RE, Carey DJ, Elmore JR, Tsao PS, Grarup N, Jorgensen T, Witte DR, Hansen T, Pedersen O, Pola R, Gaetani E, Magnadottir HB, Wijmenga C, Tromp G, Ronkainen A, Ruigrok YM, Blankensteijn JD, Mueller T, Wells PS, Corral J, Soria JM, Souto JC, Peden JF, Jalilzadeh S, Mayosi BM, Keavney B, Strawbridge RJ, Sabater-Lleal M, Gertow K, Baldassarre D, Nyyssonen K, Rauramaa R, Smit AJ, Mannarino E, Giral P, Tremoli E, de FU, Humphries SE, Hamsten A, Haraldsdottir V, Olafsson I, Magnusson MK, Samani NJ, Levey AI, Markus HS, Kostulas K, Dichgans M, Berger K, Kuhlenbaumer G, Ringelstein EB, Stoll M, Seedorf U, Rothwell PM, Powell JT, Kuivaniemi H, Onundarson PT, Valdimarsson E, Matthiasson SE, Gudbjartsson DF, Thorgeirsson G, Quyyumi AA, Watkins H, Farrall M, Thorsteinsdottir U, Stefansson K. Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol 2012;60:722-729.